Abstract
Identification of potential druggable targets utilizing protein-protein interactions network (PPIN) has been emerging as a hotspot in drug discovery and development research. However, it remains unclear whether the currently used PPIN topological properties are enough to discriminate the drug targets from non-drug targets. In this study, three-step classification models using different network topological properties were designed and implemented using support vector machine (SVM) to compare the enrichment of known drug targets from non-targets. Surprisingly, none of the models was able to identify more than 75% of the true targets in the test set. It appears that the currently used simple PPIN topological properties are not likely robust enough for prediction of potential drug targets with high confidence, which also echoes similarly unsatisfying prediction data reported previously. However, we proposed that quality and quantity improvement of the protein-protein interactions (PPI) data for model training will help increasing the prediction accuracy.
Keywords: Drug targets, protein-protein interactions network, support vector machine, network topological properties.
Combinatorial Chemistry & High Throughput Screening
Title:Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?
Volume: 19 Issue: 2
Author(s): Shiliang Li, Xiaojuan Yu, Chuanxin Zou, Jiayu Gong and Xiaofeng Liu
Affiliation:
Keywords: Drug targets, protein-protein interactions network, support vector machine, network topological properties.
Abstract: Identification of potential druggable targets utilizing protein-protein interactions network (PPIN) has been emerging as a hotspot in drug discovery and development research. However, it remains unclear whether the currently used PPIN topological properties are enough to discriminate the drug targets from non-drug targets. In this study, three-step classification models using different network topological properties were designed and implemented using support vector machine (SVM) to compare the enrichment of known drug targets from non-targets. Surprisingly, none of the models was able to identify more than 75% of the true targets in the test set. It appears that the currently used simple PPIN topological properties are not likely robust enough for prediction of potential drug targets with high confidence, which also echoes similarly unsatisfying prediction data reported previously. However, we proposed that quality and quantity improvement of the protein-protein interactions (PPI) data for model training will help increasing the prediction accuracy.
Export Options
About this article
Cite this article as:
Li Shiliang, Yu Xiaojuan, Zou Chuanxin, Gong Jiayu and Liu Xiaofeng, Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?, Combinatorial Chemistry & High Throughput Screening 2016; 19(2) . https://dx.doi.org/10.2174/1386207319666151110122145
DOI https://dx.doi.org/10.2174/1386207319666151110122145 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Nitric Oxide Production and Signaling in Inflammation
Current Drug Targets - Inflammation & Allergy Current Phthalocyanines Delivery Systems in Photodynamic Therapy: An Updated Review
Current Medicinal Chemistry Nutritional and Therapeutic Potential of Garlic and Onion (Allium sp.)
Current Nutrition & Food Science Vitamin D and Sepsis: From Associations to Causal Connections
Inflammation & Allergy - Drug Targets (Discontinued) A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs
Mini-Reviews in Medicinal Chemistry Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
CNS & Neurological Disorders - Drug Targets Dendritic Cells in Pathogenesis of COPD
Current Pharmaceutical Design An Evidence-Based Review of the Mechanism of Action, Efficacy, and Safety of Biologic Therapies in the Treatment of Psoriasis and Psoriatic Arthritis
Current Medicinal Chemistry Bioengineering RNA Silencing Across the Life Kingdoms
Recent Patents on Biotechnology Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Whole Cell Biocatalysts for the Preparation of Nucleosides and their Derivatives
Current Pharmaceutical Design Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Helminth Infections and Cardiovascular Diseases: Toxocara Species is Contributing to the Disease
Current Cardiology Reviews Piperine: Medicinal, Analytical and Therapeutics perspective
Current Bioactive Compounds Bacterial Proteases in Disease – Role in Intracellular Survival, Evasion of Coagulation/ Fibrinolysis Innate Defenses, Toxicoses and Viral Infections
Current Pharmaceutical Design Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry Antimicrobial and Biofilm Inhibiting Diketopiperazines
Current Medicinal Chemistry A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Synthesis and Enzymological Characterization of Some 2-(Substitutedphenylamino) quinazolin-4(3H)-one Derivatives as Potent α-Glucosidase Inhibitors In Vitro
Letters in Drug Design & Discovery